Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy. | Dr. wael mansour

Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy.

Citation:: Ramadan, W. S., C. G. Vazhappilly, E. M. Saleh, V. Menon, A. M. AlAzawi, A. T. El-Serafi, W. Y. Mansour, and R. El-Awady, "Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy.", Cancers, vol. 11, issue 1, pp. 13-39, 2019.